CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Endpoints News
Original article

Travere CEO Eric Dube on deciding to leave; Roche tees up a board seat for ex-Takeda chief

Neutral
AI Analysis

Summary

Travere Therapeutics will appoint Bradley Campbell, former CEO of Amicus Therapeutics, as its new CEO effective December 1, replacing Eric Dube after nearly eight years. Roche is offering a board seat to an ex-Takeda chief.

Importance:4/10
Sentiment:
0.00
management changeCEO transitionleadership
Related Companies

Read the original article

Published by Endpoints News on September 25, 2026 11:00 AM

Read Original